(PHAT) Phathom - Performance -9.1% in 12m
PHAT performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-78.89%
#149 in Peer-Group
Rel. Strength
32.11%
#5165 in Stock-Universe
Total Return 12m
-9.06%
#106 in Peer-Group
Total Return 5y
-75.34%
#126 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 19.50 USD |
| 52 Week Low | 2.29 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 98.37 |
| Buy/Sell Signal +-5 | 1.26 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: PHAT (-9.1%) vs XLV (-5.1%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-4.5% | 145% | 360% | 61.3 | 55.3 | 0.61 | 23.7% | -5.15% |
| LLY NYSE Eli Lilly |
12% | -6.78% | 514% | 66.1 | 37 | 1.24 | 58.2% | 18.9% |
| NVS NYSE Novartis |
10.1% | 17.9% | 81.6% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| NOVN SW Novartis |
7.55% | 7.58% | 54.8% | 18.7 | 14.1 | 1.38 | 9.80% | 11.2% |
| SFZN SW Siegfried Holding |
-0.63% | 2.28% | 140% | 26.1 | 25 | 1.48 | 77.8% | 77.6% |
| GSK NYSE GlaxoSmithKline |
10% | 4.92% | 57.7% | 19.9 | 9.2 | 0.4 | -25.2% | 3.11% |
| AZN NASDAQ AstraZeneca |
9.51% | -4.27% | 58.6% | 28.9 | 15.9 | 0.96 | 52.7% | 22.3% |
| IPN PA Ipsen |
2.14% | -13% | 54.2% | 24.4 | 10.3 | 0.74 | -6.40% | -6.33% |
Performance Comparison: PHAT vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for PHAT
| Total Return (including Dividends) | PHAT | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 205.75% | 4.35% | 1.11% |
| 3 Months | 119.83% | -6.89% | 5.58% |
| 12 Months | -9.06% | -5.08% | 10.51% |
| 5 Years | -75.34% | 50.53% | 109.12% |
| Trend Score (consistency of price movement) | PHAT | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 88.1% | 65.8% | 69.9% |
| 3 Months | -16.8% | -72% | 69.3% |
| 12 Months | -81.2% | -62.2% | 43.2% |
| 5 Years | -77.3% | 88.5% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | #2 | 193.01% | 202.40% |
| 3 Month | #3 | 136.10% | 108.22% |
| 12 Month | #106 | -4.19% | -17.71% |
| 5 Years | #127 | -83.62% | -88.21% |
FAQs
Does Phathom (PHAT) outperform the market?
No,
over the last 12 months PHAT made -9.06%, while its related Sector, the Health Care Sector SPDR (XLV) made -5.08%.
Over the last 3 months PHAT made 119.83%, while XLV made -6.89%.
Performance Comparison PHAT vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
PHAT vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 21% | 204.6% | 31.7% | -20% |
| US NASDAQ 100 | QQQ | 21.2% | 204.3% | 32.5% | -18% |
| German DAX 40 | DAX | 23.2% | 206.5% | 15.4% | -39% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 21.2% | 206.7% | 29.9% | -21% |
| Hongkong Hang Seng | HSI | 20.5% | 200.7% | 12.7% | -36% |
| India NIFTY 50 | INDA | 22.7% | 207.1% | 32.7% | -8% |
| Brasil Bovespa | EWZ | 18.6% | 205.3% | 11.5% | -18% |
PHAT vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 21.3% | 204.3% | 28.9% | -32% |
| Consumer Discretionary | XLY | 21.5% | 207.6% | 41.6% | -27% |
| Consumer Staples | XLP | 21.3% | 206% | 30.2% | -16% |
| Energy | XLE | 15.1% | 202.8% | 28.1% | -12% |
| Financial | XLF | 22.5% | 208.3% | 28.9% | -33% |
| Health Care | XLV | 19% | 201.4% | 32.2% | -4% |
| Industrial | XLI | 22% | 205.4% | 26.2% | -27% |
| Materials | XLB | 21.6% | 204.4% | 30.9% | -8% |
| Real Estate | XLRE | 20.4% | 204.8% | 30.7% | -22% |
| Technology | XLK | 20.7% | 203.7% | 31.3% | -13% |
| Utilities | XLU | 19.6% | 205.2% | 23.4% | -30% |
| Aerospace & Defense | XAR | 22% | 200% | 14.8% | -52% |
| Biotech | XBI | 21.3% | 198% | 42.5% | -1% |
| Homebuilder | XHB | 22.6% | 210.8% | 47.1% | 0% |
| Retail | XRT | 24.9% | 205.9% | 39.7% | -10% |
PHAT vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 9.2% | 187% | 21.9% | -12% |
| Natural Gas | UNG | 21.7% | 208.4% | 13.4% | 6% |
| Gold | GLD | 17.4% | 199.6% | 1.6% | -56% |
| Silver | SLV | 21.8% | 194.4% | 12.1% | -32% |
| Copper | CPER | 23.5% | 204% | 16.8% | -17% |
PHAT vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 19.5% | 205.1% | 33.2% | -5% |
| iShares High Yield Corp. Bond | HYG | 20.5% | 205.2% | 28% | -18% |